Showing results (191-200 of 411) with videos related to
Sort By:
Pageof 42
Scientific Reports|June 9, 2021
FGF23, a novel muscle biomarker detected in the early stages of ALSYing Si, Mohamed Kazamel, Michael Benatar, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 29, 2018
Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography systemJeremy M Shefner, Seward B Rutkove, James B Caress, et al.JCI Insight|May 17, 2019
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosisIlya Gertsman, Joanne Wuu, Melissa McAlonis-Downes, et al.Neurology. Clinical Practice|December 29, 2023
Blepharoclonus in ParkinsonismJason Margolesky, Matthew Feldman, Sarah Marmol, et al.Brain : a Journal of Neurology|July 19, 2025
Neurodegenerative disease in C9orf72 repeat expansion carriers: population risk and effect of UNC13AJiali Gao, Andrew G L Douglas, Christos V Chalitsios, et al.Expert Opinion on Drug Discovery|March 3, 2025
Drug repurposing in amyotrophic lateral sclerosis (ALS)Emily Carroll, Jakub Scaber, Kilian V M Huber, et al.Academic Radiology|August 13, 2013
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysisBradley R Foerster, Ben A Dwamena, Myria Petrou, et al.Nature Reviews. Neurology|May 20, 2024
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Joanne Wuu, Edward D Huey, et al.European Journal of Neurology|December 30, 2021
Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosisStephanie R Shepheard, Vassilios Karnaros, Beben Benyamin, et al.Brain : a Journal of Neurology|October 22, 2021
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseasesMichael Benatar, Joanne Wuu, Caroline McHutchison, et al.Pageof 42